PharmaVoice 10. Dez. 2025 Another genetic testing company? Why a different approach could boost drug predictions and R&D.
PharmaVoice 4. Dez. 2025 BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?
PharmaVoice 3. Dez. 2025 Hemophilia gene therapies are struggling on the market, even as innovation soars
PharmaVoice 1. Dez. 2025 Redefining CAR-T speed and strength with DAR-T™: A conversation with Nicholas Kirian
PharmaVoice 24. Nov. 2025 Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers